Edition:
United States

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

4.57USD
12:50pm EDT
Change (% chg)

$-0.09 (-2.03%)
Prev Close
$4.67
Open
$4.67
Day's High
$4.67
Day's Low
$4.57
Volume
211
Avg. Vol
7,153
52-wk High
$6.01
52-wk Low
$2.84

Latest Key Developments (Source: Significant Developments)

ICAD Inc ‍announces approval of Xoft Axxent balloon applicators by China FDA
Wednesday, 30 Aug 2017 08:00am EDT 

Aug 30 (Reuters) - ICAD Inc :ICAD Inc - ‍announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer​.  Full Article

ICAD reports Q2 loss per share $0.16
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 9 (Reuters) - iCAD Inc -:iCAD reports second quarter 2017 financial results and announces $13 million credit facility with silicon valley bank.Q2 gaap loss per share $0.16.Q2 revenue fell 13 percent to $6.4 million.  Full Article

Icad Q1 revenue rose 12.5 percent to $6.8 million
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - Icad Inc :Icad reports first-quarter 2017 financial results.Q1 revenue rose 12.5 percent to $6.8 million.Q1 loss per share $0.03.Q1 adjusted non-GAAP loss per share $0.18.  Full Article

ICAD says receives FDA approval for PowerLook Tomo Detection
Monday, 27 Mar 2017 08:00am EDT 

ICAD Inc :ICAD receives FDA approval for PowerLook Tomo Detection.  Full Article

Icad Q4 adjusted non-gaap loss per share $0.20
Wednesday, 8 Mar 2017 04:01pm EST 

Icad Inc : Icad reports fourth quarter and full year 2016 financial results . Q4 revenue fell 9 percent to $6.9 million . Q4 adjusted non-gaap loss per share $0.20 .Q4 loss per share $0.20.  Full Article

Icad says entered into asset purchase agreement with Invivo Corp- SEC filing
Thursday, 22 Dec 2016 02:36pm EST 

Icad Inc - : Icad - On Dec 16, 2016, co entered into an asset purchase agreement between company and Invivo Corporation - SEC filing . Icad - Purchase agreement provides for a purchase price for assets of $3.2 million less a holdback reserve amount of $350,000 .Icad Inc - If closing of agreement does not occur on or before February 15, 2017, either party has right to terminate.  Full Article

Icad says Q2 loss per share $0.10
Wednesday, 27 Jul 2016 04:05pm EDT 

Icad Inc : Icad reports second quarter 2016 financial results . Q2 revenue fell 34 percent to $7.4 million . Q2 loss per share $0.10 . Q2 adjusted non-gaap loss per share $0.09 .Icad inc says company is not providing financial guidance at this time.  Full Article

BRIEF-ICAD Inc ‍announces approval of Xoft Axxent balloon applicators by China FDA

* ICAD Inc - ‍announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer​ Source text for Eikon: Further company coverage: